Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity.
Abela IA, Pasin C, Schwarzmüller M, Epp S, Sickmann ME, Schanz MM, Rusert P, Weber J, Schmutz S, Audigé A, Maliqi L, Hunziker A, Hesselman MC, Niklaus CR, Gottschalk J, Schindler E, Wepf A, Karrer U, Wolfensberger A, Rampini SK, Meyer Sauteur PM, Berger C, Huber M, Böni J, Braun DL, Marconato M, Manz MG, Frey BM, Günthard HF, Kouyos RD, Trkola A. Abela IA, et al. Among authors: schwarzmuller m. Nat Commun. 2021 Nov 18;12(1):6703. doi: 10.1038/s41467-021-27040-x. Nat Commun. 2021. PMID: 34795285 Free PMC article.
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response.
Marconato M, Abela IA, Hauser A, Schwarzmüller M, Katzensteiner R, Braun DL, Epp S, Audigé A, Weber J, Rusert P, Schindler E, Pasin C, West E, Böni J, Kufner V, Huber M, Zaheri M, Schmutz S, Frey BM, Kouyos RD, Günthard HF, Manz MG, Trkola A. Marconato M, et al. Among authors: schwarzmuller m. J Clin Invest. 2022 Jun 15;132(12):e158190. doi: 10.1172/JCI158190. J Clin Invest. 2022. PMID: 35482408 Free PMC article. Clinical Trial.
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
Abela IA, Schwarzmüller M, Ulyte A, Radtke T, Haile SR, Ammann P, Raineri A, Rueegg S, Epp S, Berger C, Böni J, Manrique A, Audigé A, Huber M, Schreiber PW, Scheier T, Fehr J, Weber J, Rusert P, Günthard HF, Kouyos RD, Puhan MA, Kriemler S, Trkola A, Pasin C. Abela IA, et al. Among authors: schwarzmuller m. mBio. 2024 Feb 14;15(2):e0272223. doi: 10.1128/mbio.02722-23. Epub 2024 Jan 25. mBio. 2024. PMID: 38270455 Free PMC article.
Deciphering factors linked with reduced SARS-CoV-2 susceptibility in the Swiss HIV Cohort Study.
Abela IA, Hauser A, Schwarzmüller M, Pasin C, Kusejko K, Epp S, Cavassini M, Battegay M, Rauch A, Calmy A, Notter J, Bernasconi E, Fux CA, Leuzinger K, Perreau M, Ramette A, Gottschalk J, Schindler E, Wepf A, Marconato M, Manz MG, Frey BM, Braun DL, Huber M, Günthard HF, Trkola A, Kouyos RD; Swiss HIV Cohort Study. Abela IA, et al. Among authors: schwarzmuller m. J Infect Dis. 2024 Jan 16:jiae002. doi: 10.1093/infdis/jiae002. Online ahead of print. J Infect Dis. 2024. PMID: 38227786 Free article.
HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11.
Zimmermann C, Kowalewski D, Bauersfeld L, Hildenbrand A, Gerke C, Schwarzmüller M, Le-Trilling VTK, Stevanovic S, Hengel H, Momburg F, Halenius A. Zimmermann C, et al. Among authors: schwarzmuller m. PLoS Pathog. 2019 Sep 17;15(9):e1008040. doi: 10.1371/journal.ppat.1008040. eCollection 2019 Sep. PLoS Pathog. 2019. PMID: 31527904 Free PMC article.